Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Yanling Chen

1PUBLICATIONS

9CO-AUTHORS

Predictive and prognostic markers

Featured researcher

Get your video featured.

Publish with JoVE

Featured researcher

Get your video featured.

Publish with JoVE

Publications (1)

Sort by Publication Date:

|Mar 16, 2026

ETS1-Driven Transcriptional Activation of USP43 Promotes Lenvatinib Resistance in Hepatocellular Carcinoma through MYH9 Stabilization and AKT/BAD Signaling.

Wen Chen, Zhenheng Wu, Wei Pan

Pageof 1

Frequent Collaborators

1 joint publications

Wen Chen

1 joint publications

Zhenheng Wu

1 joint publications

Wei Pan

1 joint publications

Lupeng Wu

1 joint publications

Shenzhe Lin

1 joint publications

Xiahenazi Abudukeremu

1 joint publications

Canze Wu

1 joint publications

Xinyue Yang

1 joint publications

Feifei She

Frequent Collaborators

1 joint publications

Wen Chen

1 joint publications

Zhenheng Wu

1 joint publications

Wei Pan

1 joint publications

Lupeng Wu

Top Related Videos

Drug-Induced Senescence in Liver Cells Promotes M2 Macrophage Polarization: Implications for Tyrosine Kinase Inhibitor-Associated Hepatotoxicity

Drug-Induced Senescence in Liver Cells Promotes M2 Macrophage Polarization: Implications for Tyrosine Kinase Inhibitor-Associated Hepatotoxicity

Published on : Oct 17, 2025

See more related videos

Top Related Videos

Drug-Induced Senescence in Liver Cells Promotes M2 Macrophage Polarization: Implications for Tyrosine Kinase Inhibitor-Associated Hepatotoxicity

Drug-Induced Senescence in Liver Cells Promotes M2 Macrophage Polarization: Implications for Tyrosine Kinase Inhibitor-Associated Hepatotoxicity

Published on : Oct 17, 2025

See more related videos